Investors - Imexpharm

Financial information

IMP - 1Q and 4M 2026 Business Results

IMP – Explanation of change in Profit after tax in Q1/2026

IMP - Financial Statement Q1/2026

IMP - Press release: Imexpharm Corporation announces first quarter 2026 business results

IMP - 2M2026 Business Updates

IMP - Audited Financial Statements for the year end 31 Dec 2025

IMP - 4Q2025 and FY2025 business results

IMP - Press release: Imexpharm Corporation announces 4Q2025 and FY2025 business results

IMP – Explanation of change in Profit after tax in Q4.2025

IMP - 1Q and 4M 2026 Business Results

IMP - Press release: Imexpharm Corporation announces first quarter 2026 business results

IMP - 2M2026 Business Updates

IMP - 4Q2025 and FY2025 business results

IMP - Press release: Imexpharm Corporation announces 4Q2025 and FY2025 business results

IMP - 11M2025 Business Updates

IMP - 10M2025 Business Updates

IMP - 3Q and 9M 2025 Business Results

IMP - Press release: Imexpharm Corporation announces 3Q2025 and 9M2025 business results

IMP – Explanation of change in Profit after tax in Q1/2026

IMP - Financial Statement Q1/2026

IMP - Audited Financial Statements for the year end 31 Dec 2025

IMP – Explanation of change in Profit after tax in Q4.2025

IMP - Financial Statement Q4. 2025

IMP - Financial Statement Q3. 2025

IMP - Disclosure of reviewed 6 month 2025 Financial statements and explanation for PAT growth

IMP - Disclosure of Q2.2025 Financial Statements and Explanation for PAT growth

IMP - Financial Statement Q1. 2025

Annual Report & Sustainability Report

Sustainability Report 2025

Sustainability Report 2025

Annual Report 2025

Annual Report 2025

Annual Report 2024 (Digital version)

Annual Report 2024 (Digital version)

Sustainability Report 2024

Sustainability Report 2024

Annual Report 2024 (PDF version)

Annual Report 2024 (PDF version)

Sustainability Report 2023

Sustainability Report 2023

Annual Report 2023 (Digital version)

Annual Report 2023 (Digital version)

Annual Report 2023 (PDF version)

Annual Report 2023 (PDF version)

Sustainability Report 2022

Sustainability Report 2022

Annual Report 2025

Annual Report 2025

Annual Report 2024 (Digital version)

Annual Report 2024 (Digital version)

Annual Report 2024 (PDF version)

Annual Report 2024 (PDF version)

Annual Report 2023 (Digital version)

Annual Report 2023 (Digital version)

Annual Report 2023 (PDF version)

Annual Report 2023 (PDF version)

Annual Report 2022

Annual Report 2022

Annual Report 2021

Annual Report 2021

Annual Report 2020

Annual Report 2020

Annual Report 2019

Annual Report 2019

Sustainability Report 2025

Sustainability Report 2025

Sustainability Report 2024

Sustainability Report 2024

Sustainability Report 2023

Sustainability Report 2023

Sustainability Report 2022

Sustainability Report 2022

Sustainability Report 2021

Sustainability Report 2021

Sustainability Report 2020

Sustainability Report 2020

Sustainability Report 2019

Sustainability Report 2019

Sustainability Report 2018

Sustainability Report 2018

AGM

IMP - Resolution of the 2026 AGM

04/23/2026

IMP - Meeting minutes of the 2026 AGM

04/23/2026

IMP - Documents for the 2026 Annual General Meeting of Shareholders

03/25/2026

IMP - Notice of the convening of the 2026 AGM

03/25/2026

IMP - The Minutes of Vote counting result and the Resolution of the GMS approving certain matters via written consultation

10/29/2025

IMP - Annoucement of collecting GMS’s opinions in writing

10/14/2025

IMP - Official letter amending the Resolution and Minutes of the 2025 AGM

05/15/2025

IMP - Meeting minutes of the 2025 AGM

04/26/2025

IMP - Documents for the 2026 Annual General Meeting of Shareholders

03/25/2026

IMP - Notice of the convening of the 2026 AGM

03/25/2026

IMP - Annoucement of collecting GMS’s opinions in writing

10/14/2025

IMP - Documents for the 2025 Annual General Meeting of Shareholders

04/03/2025

IMP - Announcement attend the AGM 2025

03/28/2025

IMP - Documents to collect GMS's opinions in writing (2nd time in 2024)

10/17/2024

IMP - Documents to collect GMS's opinions in writing

07/25/2024

IMP - Documents of the 2024 AGM

04/05/2024

IMP - Resolution of the 2026 AGM

04/23/2026

IMP - Meeting minutes of the 2026 AGM

04/23/2026

IMP - The Minutes of Vote counting result and the Resolution of the GMS approving certain matters via written consultation

10/29/2025

IMP - Official letter amending the Resolution and Minutes of the 2025 AGM

05/15/2025

IMP - Meeting minutes of the 2025 AGM

04/26/2025

IMP - Resolution of the 2025 AGM

04/26/2025

IMP - Resolution of the GMS No. 04 approving the implementation of the Cat Khanh Pharmaceutical Factory Complex Project

10/30/2024

IMP - Resolution of the GMS No. 03 approving certain issues by collecting written opinions

10/30/2024

Corporate Governance

IMP - Imexpharm Corporation’s amended and supplemented Charter was approved by the GMS on April 22, 2026

04/23/2026

IMP - Report on Corporate Governance for 2025

01/30/2026

IMP - The BOD’s Resolution on the issuance of the Information Disclosure Regulations (2nd amendment)

01/08/2026

IMP - Report on Corporate Governance for 1H2025

07/25/2025

IMP - Imexpharm's Charter - April 2025 (amended on May 15, 2025)

05/15/2025

IMP - Internal regulations on Corporate Governance - April 2025

04/26/2025

IMP - Imexpharm's Charter - April 2025

04/26/2025

IMP - Nomination and Compensation Committee Regulation

02/24/2025

IMP - Imexpharm Corporation’s amended and supplemented Charter was approved by the GMS on April 22, 2026

04/23/2026

IMP - The BOD’s Resolution on the issuance of the Information Disclosure Regulations (2nd amendment)

01/08/2026

IMP - Imexpharm's Charter - April 2025 (amended on May 15, 2025)

05/15/2025

IMP - Internal regulations on Corporate Governance - April 2025

04/26/2025

IMP - Imexpharm's Charter - April 2025

04/26/2025

IMP - Nomination and Compensation Committee Regulation

02/24/2025

IMP - Regulation on operation of Audit Committee

02/24/2025

IMP - Imexpharm's Charter - October 2024

10/01/2024

IMP - Report on Corporate Governance for 2025

01/30/2026

IMP - Report on Corporate Governance for 1H2025

07/25/2025

IMP - Report on Corporate Governance for 2024

01/23/2025

IMP - Report on Corporate Governance for 1H2024

07/30/2024

IMP: Report on Corporate Governance in 2023

01/30/2024

IMP: Report on Corporate Governance for the first 6 months of 2023

07/28/2023

IMP – Report on Corporate Governance in 2022

01/30/2023

IMP - Report on Corporate Governance for 1H2022

07/25/2022

Imexpharm – Prospectus for Public Offering of Shares 2010

11/16/2010

Information Disclosure

IMP - HOSE: Announcement on the record date for collecting shareholders' written opinions in 2026

05/27/2026

IMP - VSDC: Notice of the record date for the exercise of securities holders' rights

05/26/2026

IMP - Announcement on the record date for exercising the right to collect shareholders’ written opinions 2026

05/25/2026

IMP - Notice of nomination and self-nomination of candidates for members of the BOD for the remainder of the 2023-2027 term

05/25/2026

IMP - BOD Resolution No. 11 on soliciting shareholder written opinions to implement the plan for restructuring the composition of the BOD for the remainder of the 2023-2027 term

05/25/2026

IMP - Imexpharm Corporation announces its plan to restructure the Board of Directors

05/22/2026

IMP - Imexpharm announces the receipt of resignation letters from members of the Board of Directors

05/19/2026

IMP - Board of Directors’ Resolution approving the appointment of the Independent Auditor for the fiscal year 2026

05/15/2026

Analyst Report

Analyst Report

HSC - Initial Valuation Report

SSI - Valuation update report

FPTS - Valuation update report

PHS - Flash Note: Leading position, Sustainable growth

PHS - Company meeting note

SSI - Positive Outlook for 2H and Beyond

VDSC - Business update 1Q2024

Vietcap - Visit note

FPTS - Valuation update report

News - Events

IMP - Imexpharm Corporation announces its plan to restructure the Board of Directors

05/22/2026

IMP - Imexpharm Corporation announces its plan to restructure the Board of Directors

Imexpharm 1Q2026 Earnings Call Invitation

05/11/2026

Imexpharm 1Q2026 Earnings Call Invitation

IMP - Press Release: 2026 Annual General Meeting of Shareholder

IMP - Press Release: 2026 Annual General Meeting of Shareholder

04/22/2026

1Q2026 - Imexpharm Facts & Figures

1Q2026 - Imexpharm Facts & Figures

04/21/2026

4Q & FY2025 - Imexpharm Facts & Figures

4Q & FY2025 - Imexpharm Facts & Figures

01/27/2026

Imexpharm 4Q2025 Earnings Call Invitation

Imexpharm 4Q2025 Earnings Call Invitation

01/27/2026

Top 50 best listed companies

Top 50 best listed companies

In 2024, Imexpharm was voted Top 50 best listed companies of the year by Forbes Vietnam Magazine. Being named on the list for the third time, Imexpharm shows its solid preparation of internal strength, ready for the next steps on its 47-year development journey.